CD83+ dendritic cells and Foxp3+ regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer

Gastric Cancer

Volumn 15, Issue 2, 2012, Pages 144-153

  Seigo Kashimura, ^a   Saze, Zenichiro ^a   Terashima, Masanori ^b   Soeta, Nobutoshi ^a   Ohtani, Satoshi ^a   Osuka, Fumihiko ^a   Kogure, Michihiko ^a   Gotoh, Mitsukazu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Dendritic cells; Gastric cancer; Prognosis; Regulatory T cells

Indexed keywords

CD83 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CD83+ DENDRITIC CELL; CELL DENSITY; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; FOXP3+ REGULATORY T CELL; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; REGIONAL METASTASIS; REGULATORY T LYMPHOCYTE; STOMACH CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84861528483     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0090-9     Document Type: Article

References (44)

1. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811. (Pubitemid 30365397)
2. Zhou LJ, Schwarting R, Smith HM, Tedder TF. A novel cellsurface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol. 1992;149:735-42.
3. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 1995;154:3821-35.
4. Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells are located in peritumoral areas. J Exp Med. 1999;190:1417-25.
5. Zhou L, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Immunology. 1999;93:2588-92. (Pubitemid 26104391)
6. Thurner M, Radmayr C, Ramoner R, et al. Human renal-cell carcinoma tissue contain dendritic cells. Int J Cancer. 1996;68:1-7. (Pubitemid 26354569)
7. Tsukayama S, Omura K, Yoshida K, Tanaka Y, Watanabe G. Prognostic value of CD83 positive mature dendritic cells and their relation to vascular endothelial growth factor in advanced human gastric cancer. Oncol Rep. 2005;14:369-75.
8. Saito H, Osaki T, Murakami D, et al. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters. J Surg Oncol. 2007;95:123-8. (Pubitemid 46238980)
9. Naito Y, Saito K, Shibata K, et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58:3491-4. (Pubitemid 28376536)
10. Furihata M, Ono Y, Ichikawa K, Tomita S, Fujimori T, Kubota K. Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma. Oncol Rep. 2005;14:353-6.
11. Miyagawa S, Soeda J, Takagi S, Miwa S, Ichikawa E, Noike T. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. Hum Pathol. 2004;35:1392-6. (Pubitemid 39601580)
12. Iwamoto M, Shinohara H, Miyamoto A, et al. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer. 2003;104:92-7. (Pubitemid 36184151)
13. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001;193:1285-94. (Pubitemid 32524778)
14. Ng WF, Duggan PJ, Ponchel F, et al. Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood. 2001;98:2736-44.
15. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). J Immunol. 1995;155:1151-64.
16. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8-27. (Pubitemid 44116697)
17. Dejaco C, Dultner C, Grubeck B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology. 2005;117:289-300.
18. Beyer M, Schulze JL. Regulatory T cells in cancer. Blood. 2006;108:804-11. (Pubitemid 44154611)
19. Viehl C, Moore T, Liyanaga U, et al. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice. Ann Surg Oncol. 2005;13:1252-8. (Pubitemid 44440427)
20. Rudge G, Barrett SP, Scott B, Driel IR. Infiltration of a mesothelioma by IFN-c-producing cells and tumor rejection after depletion of regulatory T cells. J Immunol. 2007;178:4089-96. (Pubitemid 46492357)
21. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cells development by the transcription factor Foxp3. Science. 2003;299:1057-61. (Pubitemid 36222930)
22. Fontenot JD, Gavin MA, Rudensky A. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;10:1330-6.
23. Fontenot JD, Rasmussen JP, Williams M, Dooley L, Farr AG, Rudensky Y, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22:329-41. (Pubitemid 40387475)
24. Woo EY, Chu CS, Goletz TJ, et al. Regulatory CD4+CD25+T cells in tumors from patients with early-stage non-small cell lung cancer and last-stage ovarian cancer. Cancer Res. 2001;61: 4766-72. (Pubitemid 32691889)
25. Badoual C, Hans S, Rodriguez J, et al. Prognostic value of tumorinfiltrating C? T cells subpopulations in head and neck cancers. Clin Cancer Res. 2006;12:465-72. (Pubitemid 43166137)
26. Wolf D, Wolf A, Rumpold H, et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res. 2005;11:8326-31. (Pubitemid 41746944)
27. Kobayashi N, Hiraoka N, Yamagami W, et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res. 2007;13:902-11. (Pubitemid 46340366)
28. Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res. 2006;12:5423-34. (Pubitemid 44497257)
29. Mizukami Y, Kono K, Kawaguchi Y, et al. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer. 2008;98:148-53.
30. Siddiqui SA, Frigola X, Bonne-Annee S, et al. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res. 2007;13:2075-81. (Pubitemid 46649875)
31. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer. 1998;1:10-24.
32. Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer. 1990;66:2012-6. (Pubitemid 20385978)
33. Dadabayev A, Sandel M, Menon A, et al. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother. 2004;53:978-86. (Pubitemid 39371742)
34. Miyake M, Taki T, Hitomi S, Hakomori S. Correlation of expression of H/Ley/Leb antigen with survival in patients with carcinoma of the lung. N Engl J Med. 1992;327:14-8.
35. Matsuda H, Mori M, Tsujitani S, Ohno S, Kuwano H, Sugimachi K. Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein-positive cells in human malignant esophageal tissues. Cancer. 1990;65:2261-5. (Pubitemid 20164833)
36. Schwaab T, Weiss JE, Schned AR, Barth RJ Jr. Dendritic cell infiltration in colon cancer. J Immunother. 2001;24:130-7. (Pubitemid 32183059)
37. Kawaida H, Kono K, Takahashi A, et al. Distribution of CD4(?)CD25high regulatoryT-cells in tumor-draininglymph nodes in patients with gastric cancer. J Surg Oncol. 2005;124:151-7. (Pubitemid 40269816)
38. Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factorbeta1 mediates suppression in the tumor microenvironment. Clin Cancer Res. 2007;13:4345-54. (Pubitemid 47219698)
39. Sarrs M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin- 1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity. 2008;28:402-13.
40. Terme M, Chaput N, Combadiere B, Ma A, Ohteki T, Zitvogel L. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J Immunol. 2008;180:4679-86.
41. Fehervari A, Sakaguchi S. Control of Foxp3+CD4+ regulatory cell activation and function by dendritic cells. Int Immunol. 2004;16:1769-80. (Pubitemid 40003865)
42. Yamaguchi T, Hirota K, Nagahama K, et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity. 2007;27:145-59. (Pubitemid 47089022)
43. Schmidt J, Eisold S, Büchler MW, Märten A. Dendritic cells reduce number and function of CD4+CD25+ cells in cytokineinduced killer cells derived from patients with pancreatic carcinoma. Cancer Immunol Immunother. 2004;53:1018-26. (Pubitemid 39371746)
44. Van Meirvenne S, Dullaers M, Heirman C, Straetman L, Michiels A, Thielemans K. In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells. Mol Ther. 2005;12:922-32. (Pubitemid 41614488)